1. Home
  2. ZGN vs FOLD Comparison

ZGN vs FOLD Comparison

Compare ZGN & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZGN
  • FOLD
  • Stock Information
  • Founded
  • ZGN 1910
  • FOLD 2002
  • Country
  • ZGN Italy
  • FOLD United States
  • Employees
  • ZGN N/A
  • FOLD N/A
  • Industry
  • ZGN Apparel
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZGN Consumer Discretionary
  • FOLD Health Care
  • Exchange
  • ZGN Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • ZGN 2.1B
  • FOLD 2.5B
  • IPO Year
  • ZGN N/A
  • FOLD 2007
  • Fundamental
  • Price
  • ZGN $10.15
  • FOLD $8.15
  • Analyst Decision
  • ZGN Buy
  • FOLD Strong Buy
  • Analyst Count
  • ZGN 3
  • FOLD 9
  • Target Price
  • ZGN $9.40
  • FOLD $26.44
  • AVG Volume (30 Days)
  • ZGN 830.1K
  • FOLD 5.8M
  • Earning Date
  • ZGN 09-05-2025
  • FOLD 11-05-2025
  • Dividend Yield
  • ZGN 1.38%
  • FOLD N/A
  • EPS Growth
  • ZGN N/A
  • FOLD N/A
  • EPS
  • ZGN 0.43
  • FOLD N/A
  • Revenue
  • ZGN $2,248,050,499.00
  • FOLD $571,160,000.00
  • Revenue This Year
  • ZGN N/A
  • FOLD $20.98
  • Revenue Next Year
  • ZGN $4.69
  • FOLD $20.74
  • P/E Ratio
  • ZGN $23.40
  • FOLD N/A
  • Revenue Growth
  • ZGN N/A
  • FOLD 25.35
  • 52 Week Low
  • ZGN $6.05
  • FOLD $5.51
  • 52 Week High
  • ZGN $10.38
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • ZGN 67.65
  • FOLD 56.40
  • Support Level
  • ZGN $8.94
  • FOLD $7.69
  • Resistance Level
  • ZGN $10.38
  • FOLD $8.59
  • Average True Range (ATR)
  • ZGN 0.28
  • FOLD 0.37
  • MACD
  • ZGN 0.07
  • FOLD -0.05
  • Stochastic Oscillator
  • ZGN 82.01
  • FOLD 54.44

About ZGN Ermenegildo Zegna N.V.

Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: